The virus filtration market has seen considerable growth due to a variety of factors.
• In recent times, the size of the virus filtration market has experienced fast-paced growth. It is predicted to increase from $5.41 billion in 2024 to approximately $6.03 billion in 2025, signaling a compound annual growth rate (CAGR) of 11.4%. Factors such as expanding biopharmaceutical production, heightened instances of viral contaminations, the worldwide growth of biopharmaceutical firms, enhanced cognizance of viral safety, prioritization of monoclonal antibody production, rising demand for single-use systems, amplified biomanufacturing facilities, and the consistent inclusion of continuous manufacturing have propelled growth in this period.
The Virus Filtration market is expected to maintain its strong growth trajectory in upcoming years.
• The future promises a significant expansion for the virus filtration market, predicted to grow to an impressive $9.88 billion in 2029, with a compound annual growth rate (CAGR) of 13.2%.
Factors contributing to this potential growth include an increase in vaccine production, readiness for potential new viral threats, the rise of cell and gene therapy, a surge in demand for biosimilars, the creation of high-throughput systems, focus on point-of-use filtration, and continuous advancement in product design, coupled with adaptability in bioprocessing workflows. Key trends for the forecast period encompass the merging of technology and nanotechnology, incorporation of artificial intelligence (AI), the development of sustainable and customizable filtration technologies, integration of automation, increased investments in research and development, as well as a rise in technological partnerships and collaborations.
The virus filtration market's growth is being fueled by an uptick in chronic diseases. Chronic ailments are those that persist for at least a year, requiring continuous medical care or hindering day-to-day routine. Virus filtration contributes to the prevention of infectious and chronic diseases by removing viruses effectively, reinforcing the market's expansion. For example, the World Health Organization (WHO), a UN organization in charge of global public health, stated in its key facts released in September 2022 that noncommunicable diseases (NCDs) cause 41 million deaths annually, accounting for 74% of all global deaths. Cardiovascular diseases account for a significant portion of NCD-related deaths, affecting about 17.9 million people each year. Thus, the increasing instances of cardiovascular diseases is projected to sustain the upward trend of the virus filtration market.
The virus filtration market covered in this report is segmented –
1) By Type: Kits And Reagents, Services, Filtration Systems, Other Types
2) By Application: Medical Devices, Water Purification, Air Purification, Biologicals, Vaccines And Therapeutics, Blood And Blood Products, Cellular And Gene Therapy Products, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Medical Device Companies
Subsegments:
1) By Kits And Reagents: Sample Preparation Kits, Assay Kits, Detection Reagents
2) By Services: Custom Virus Filtration Services, Validation And Testing Services, Consulting Services
3) By Filtration Systems: Membrane Filtration Systems, Depth Filtration Systems, Tangential Flow Filtration Systems, Ultra-Filtration Systems
4) By Other Types: Accessories And Consumables, Virus Filtration Equipment, Combination Systems
The virus filtration market is witnessing significant developments due to technological advancements. Prominent enterprises in this sector are pushing for innovative technological solutions to consolidate their market position. For instance, Integrated Viral Protection (IVP), an American technology startup, unveiled a sophisticated airborne virus filtration unit at the tech event CES 2022 in Las Vegas, USA, in January 2022. This state-of-the-art device eradicates airborne viruses in one sweep, including the sub-micron variants responsible for COVID-19, anthrax spores, and allergens. The technology is built on IVP's unique 'catch and kill virus' patent, specifically designed to counter airborne viruses.
Major companies operating in the virus filtration market include:
• Merck & Company Inc.
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Lonza Group Ltd.
• Pall Corporation
• Charles River Laboratories International Inc.
• Sartorius AG
• Asahi Kasei Medical Co. Ltd.
• WuXi AppTec
• Danaher Corporation
• Sigma-Aldrich Corporation
• Pendotech
• Purafil Inc.
• Parker Hannifin Corporation
• Eaton Corporation
• Freudenberg Group
• Entegris Inc.
• Meissner Filtration Products Inc.
• Koch Membrane Systems Inc.
• Graver Technologies LLC
• Amazon Filters Ltd.
• Cobetter Filtration Equipment Co. Ltd.
• Sterlitech Corporation
• Membrane Solutions LLC
• Advantec MFS Inc.
• GVS Group
• Porvair Filtration Group
North America was the largest region in the virus filtration market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virus filtration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.